Literature DB >> 9593479

Invasive pneumococcal infection in South and West England.

M D Smith1, J Stuart, N J Andrews, W A Telfer Brunton, K A Cartwright.   

Abstract

Variation in the incidence of invasive pneumococcal disease across South and West England, in 1995, was measured through a survey of microbiology laboratories. A 100% response rate was achieved. The incidence by laboratory varied between 5.2 and 20.4 per 100,000 catchment population (P < 0.001). Adjusting for pneumococcal vaccine uptake rate in over 65 year olds, hospital admission rates, blood culture system used and for the age and sex structure of the population, did not account for this variation. When blood culture sampling rates were included in a logistic regression model, the variation between laboratories was much less and of lower statistical significance (P = 0.019). Higher rates of blood culture sampling were associated with a higher incidence of invasive pneumococcal disease. Consistently high sampling should be encouraged because a higher diagnostic rate should result in more selective prescribing of antibiotics, and secondly because improved ascertainment of severe pneumococcal infections is a prerequisite for the evaluation of new pneumococcal conjugate vaccines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593479      PMCID: PMC2809379          DOI: 10.1017/s0950268897008522

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  10 in total

Review 1.  New pneumococcal vaccines for children.

Authors:  S Choo; A Finn
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

Review 2.  Modelling hospital admissions for lower respiratory tract infections in the elderly in England.

Authors:  B Müller-Pebody; N S Crowcroft; M C Zambon; W J Edmunds
Journal:  Epidemiol Infect       Date:  2006-05-26       Impact factor: 2.451

Review 3.  Epidemiology of pneumococcal infections in the elderly.

Authors:  J C Butler; A Schuchat
Journal:  Drugs Aging       Date:  1999       Impact factor: 3.923

Review 4.  Pneumococcal vaccination for older adults: the first 20 years.

Authors:  D S Fedson
Journal:  Drugs Aging       Date:  1999       Impact factor: 3.923

5.  Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance.

Authors:  Helle Bossen Konradsen; Margit Staum Kaltoft
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

6.  Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation.

Authors:  Michael D Smith; Petra Derrington; Rachel Evans; Marjorie Creek; Rhonwen Morris; David A B Dance; Keith Cartwright
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

7.  Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease by Streptococcus pneumoniae in Italian children.

Authors:  Chiara Azzari; Maria Moriondo; Giuseppe Indolfi; Cristina Massai; Laura Becciolini; Maurizio de Martino; Massimo Resti
Journal:  J Med Microbiol       Date:  2008-10       Impact factor: 2.472

8.  Trends in incidence of pneumococcal disease before introduction of conjugate vaccine: South West England, 1996-2005.

Authors:  C A Ihekweazu; D A B Dance; R Pebody; R C George; M D Smith; P Waight; H Christensen; K A V Cartwright; J M Stuart
Journal:  Epidemiol Infect       Date:  2007-10-26       Impact factor: 2.451

9.  The 23-valent pneumococcal polysaccharide vaccine. Part II. A cost-effectiveness analysis for invasive disease in the elderly in England and Wales.

Authors:  Alessia Melegaro; W John Edmunds
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

10.  Racial and Regional Differences in Rates of Invasive Pneumococcal Disease.

Authors:  Annabelle de St Maurice; Carlos G Grijalva; Christopher Fonnesbeck; William Schaffner; Natasha B Halasa
Journal:  Pediatrics       Date:  2015-10-12       Impact factor: 7.124

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.